TRIP Inhibitors
TRIP, also know as TRAIP (TNF Receptor-Associated Factor Interacting Protein) is a RING-type E3 ubiquitin ligase, plays a crucial role in DNA damage response and cellular mechanisms associated with the maintenance of genomic stability. The activation of TRAIP is typically initiated by replication stress or DNA double-strand breaks, and its involvement is essential for the proper progression of DNA replication, especially under conditions where the genome is under duress. TRAIP is known to regulate a variety of substrates through its E3 ligase activity, which facilitates the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to specific substrate proteins. This ubiquitination process can lead to different outcomes for the substrate protein, including changes in its activity, localization, or stability, depending on the type of ubiquitin modification added.
TRAIP inhibitors are chemical compounds designed to modulate the activity or expression of TRAIP. These inhibitors might target the protein directly or may interfere with its upstream or downstream signaling pathways. By doing so, they can influence the ubiquitination process carried out by TRAIP, affecting the fate of its substrate proteins. Given the central role of TRAIP in the DNA damage response and replication processes, its inhibitors can be used as tools to study the intricacies of these cellular mechanisms. Such compounds can provide insights into how cells respond to genomic stress, the molecular players involved, and the broader implications of perturbing these pathways. In the realm of molecular biology and biochemistry, TRAIP inhibitors serve as valuable research agents, paving the way for a deeper understanding of genomic stability and the cellular response to DNA damage.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is an anthracycline antibiotic and known to intercalate into DNA, causing DNA damage. While it primarily causes DNA damage, it may indirectly modulate the expression of genes involved in the DNA damage response, potentially including down-regulation of TRIP. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide interferes with the action of topoisomerase II, causing DNA strand breaks. Such damage might lead to altered expression of DNA repair and response proteins, which could include modulation of TRIP levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is an antimetabolite that gets incorporated into RNA and DNA, disrupting their functions. Given its broad impact on transcription and DNA synthesis, it could indirectly affect the expression of numerous genes, potentially including TRIP. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin induces DNA cross-links, leading to DNA damage. By introducing DNA damage, it might cause a cellular response that alters the expression of DNA repair genes, possibly influencing TRIP expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin targets topoisomerase I, preventing DNA relegation and leading to DNA breaks. This DNA damage could lead to a cellular response that modulates the expression of genes like TRIP involved in the DNA damage response. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is an antimetabolite and antifolate drug. It inhibits dihydrofolate reductase, affecting DNA synthesis. This may result in changes in the expression of genes related to DNA synthesis and repair, including TRIP. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, affecting DNA synthesis. Given its impact on DNA replication, it might indirectly modulate the expression of genes involved in DNA synthesis and repair, potentially impacting TRIP levels. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin induces DNA damage by causing DNA strand breaks. This damage could lead to altered expression of DNA repair and response genes, potentially influencing TRIP levels. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $36.00 $88.00 $220.00 $436.00 | 8 | |
Mimosine, a plant amino acid, can inhibit DNA synthesis. By affecting DNA replication, it might influence the expression of genes involved in DNA synthesis and repair, including potentially TRIP. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin inhibits DNA polymerase, leading to stalled DNA replication forks. This replication stress might lead to changes in the expression of genes involved in DNA replication and repair, which could include TRIP. | ||||||